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ABSTRACT 
Analysis of blood parameters is relevant to risk evaluation of alternations of the haematological system in humans and animals. Haematological 
parameters have been associated with health indices and are of diagnostic significance in routine clinical evaluation of the state of health of any 
individual. Present study was carried out to ascertain the antioxidant properties of vitamin E on haematological parameters caused by 
hexavalent chromium - Cr(VI) in laboratory chicks. Developing chicks (Croiler, body weight 100±20 gm) were used as experimental animals. 
Blood samples were collected from wing veins of chicks and analyzed after experiment. The haematological profile revealed a significant 
(p<0.05) reduction of Total Red Blood Cell count (RBC), total White Blood Cell count (WBC), Haemoglobin concentration (Hb), Packed cell 
volume (PCV) and Mean corpuscular hemoglobin concentration (MCHC) in toxin group compared to control group. However, the group of 
chicks treated with chromium and vitamin E alternatively, recorded significant increase in all these blood parameters indicating the protection 
offered by vitamin E as an ameliorating antioxidant against chromium toxicity.  
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INTRODUCTION  
Chromium is one of the major environmental toxicants that 
affect human health. It is one among the eight most common 
pollutant heavy metals listed by the Environmental 
Protection Agency1. It is a naturally occurring element found 
in rocks, volcanic dust and gasses, soils as well as plants and 
animals. This transition metal can exist in various oxidized 
forms ranging from −2 to +6. The three main oxidation forms 
of chromium, commonly found in the workplace and general 
environment, are chromium (0), chromium (III), and 
chromium (VI). Chromium (0) is the metal chromium, a 
steel-gray solid with a high melting point usually used for 
making steel and other alloys. Chromium (III) and chromium 
(VI) compounds are widely used industrially in stainless 
steel production, welding, electroplating, leather tanning, 
production of dyes and pigments, and wood preservatives2,3.  
It is well known that oral intake along with food and water is 
the major route of exposure to chromium for the general 
population. It has been reported that the chromium (VI) form 
appears to be 10-100 times more toxic than the chromium 
(III) form when both are administered by the oral route4. It is 
an establish fact that chronic diseases affect the blood cells 
adversely. Exposure to chromium, the transition element 
found in many compounds of earth’s crust, leads to various 
health hazards including cancer, dermatitis, damage of liver 
and kidneys, and alternations in haematological parameters. 
Toxic effect of chronic exposure to chromium at low 
environmentally relevant dose is recently recognized and 
less studied. 
Chromium (VI) can easily enter the cell than chromium (III) 
through SO42- and PO42- channels. After entering the cell, 
chromium (VI) undergoes a chain reaction with production 
of chromium intermediates such as chromium (V) and 
chromium (IV) by cellular reductants such as ascorbic acid 
and riboflavin, glutathione, and serum protein5. The reduced 
product binds to intracellular proteins, resulting in an 
elevation of total chromium in the blood cell for several 
weeks. During this reduction process, chromium produces 
reactive oxygen species and generates oxidative stress. This 
in turn is responsible for defective haematopoiesis6.  
It has been reported that chromium (VI) is considered as a 
toxic transition heavy metal and a potent industrial hazard 
that causes severe damage to a variety of tissues and organs 
including the reproductive system7-10. Most of the studies on 
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toxic effects of chromium involve a dose much higher than 
the amount of chromium available in drinking water and 
within the permissible limit set by the World Health 
Organization11.  
Vitamin E (α-tocopherol) is a biological antioxidant, soluble 
in fat12, which inhibits the oxidation of long chained 
unsaturated fatty acids of the cell membrane13,14. 
Unsaturated fatty acids react with oxygen, and form 
superoxide, peroxide and hydroperoxides15. These free 
radicals cause cell damage by disturbing the metabolism and 
structure of the biological membranes of those organs that 
contain excessive amount of unsaturated fatty acids16. 
Vitamin E inhibits the effects of hydrogen protons and free 
radicals by saturating them, and so inhibits auto 
oxidation13,15. It has been reported that lipid peroxidation is 
stopped in chicks fed with a vitamin E supplemented diet17. 
It has also been proposed that vitamin E inhibits the 
oxidation of unsaturated fatty acids such as linoleic acid on 
the erythrocyte membrane15, and the deficiency of this 
vitamin increases the hemolysis of red cells18,19. 
Although much research investigating the ameliorating effect 
of vitamin E on the chromium toxicity has been done on 
humans and various animals, little work has been attempted 
on animals undergoing rapid growth, such as broilers20. 
Therefore, in this study, we aimed to investigate the 
protective effects of vitamin E in the toxicity caused by 
chromium on a number of haematological parameters in 
laboratory chicks. 
OBJECTIVE OF STUDY 
The objective of the present work was to study the toxic 
effects of hexavalent chromium in the form of potassium 
dichromate (K2Cr2O7) on haematological parameters and its 
treatment with vitamin E. In this study we hypothesize that 
vitamin E act as an antioxidant against toxicity induced by 
different heavy metals and it may play an important role to 
reduce chromium induced toxicity. To prove this fact, we 
studied the protective effects of vitamin E against hexavalent 
chromium toxicity on haematological parameters. However, 
to strengthen this work, further studied are required to 
clarify the action mechanism of vitamin E as a therapeutic 
agent. This study is expected to enhance our understanding 
of harmful effects of chromium toxicity and the effectiveness 
of vitamin E to reduce chromium health hazards. An attempt 
was made to evaluate the beneficial effect of vitamin E on 
chromium mediated toxicity in order to study the role of 
vitamin E in the amelioration of the chromium intoxication. 
MATERIALS AND METHODS 
Chemicals – Hexavalent chromium - Potassium 
dichromate (K₂Cr₂O₇) was procured from Glaxo (India). 
Vitamin E (α-tocopherol) was purchased from Sigma 
Chemical Co. (St. Louis, Mo, USA). All the reagents and 
chemicals used in this study were of analytical grade and 
highest purity procured from standard commercial sources 
in India. 
Animals - The experiment was carried on Domestic chicks - 
Croiler Chabro (Gallus gallus domesticus). Newly hatched 
chicks were purchased from the Uttarakhand Village Poultry 
Project (State Govt. Poultry Farm), Bin, Pithoragarh 
(Uttarakhand). Selected all chicks were maintained and 
acclimatized according to the laboratory conditions. The 
animals were housed in battery cages under laboratory 
conditions at existing room temperature and relative 
humidity. They were fed on commercial food (Starter, 
Grower and Finisher) purchased from the local market and 
tap water ad libitum.  
Healthy male and female chicks (approximately 2-3 weeks 
old, body weight 100±20 gm) were used in present study. All 
protocols were approved by the Institutional Animal Ethics 
Committee (IAEC), Department of Pharmaceutical Science, 
Bhimtal, Kumaun University, Nainital and the member 
secretary, CPCSEA, Ministry of Environment, Forest and 
Climate Change, Government of India (Protocol No.- 
KUDOPS/89). The animals were kept under standard 
conditions throughout the experiment to reduce the error. 
Minimum number of animals was used to obtain reliable 
results. 
Experimental Treatments - The selected chicks were 
divided into three groups (A, B and C) randomly, each 
containing at least 6 chicks. Chicks of group A were 
administered with sublethal dose of potassium dichromate 
(K₂Cr₂O₇) (5 mg/100 gm body weight) dissolved in distilled 
water by gavage on each alternate day for 30 days. Chicks of 
group B were treated with potassium dichromate (K₂Cr₂O₇) 
as chicks of group A but also administered with vitamin E 
(intramuscularly) (0.5 IU/100 gm body weight) on each 
alternate day for 30 days. Chicks of Group C were 
administered with saline only to serve as purely control.  
Haematological studies – The fresh blood samples were 
collected from the wing vein using 3ml disposable syringe 
and directly transferred into labeled test tubes containing 
EDTA, as anti – coagulant, kept in an ice box, using icepacks 
and transferred to the laboratory for measuring the 
hematological parameters.  
The haematological indices determined included 
Haemoglobin concentration (Hb), White blood cell count 
(WBC), Red blood cell count (RBC), Packed cell volume(PCV) 
and Mean corpuscular hemoglobin concentration (MCHC). 
Blood cells counts were done by Neubauer double 
haemocytometer using Haem’s and Turek’s solution as 
respective diluting fluids. Haemoglobin percentage was 
measured by cyanomethemoglobin method. PCV and MCHC 
were determined by Wintrobe’s hematocrit tube method.  
Statistical analysis - Mean and standard error were 
calculated and data were analyzed using standard methods. 
Parameters of all treatments were compared using Student’s 
“t” test. Data were subjected to one way ANOVA for 
calculating the significance difference between the 
treatments. P-values less than 0.05 were considered 
statistically significant. 
RESULTS 
Table 01 shows the haematological values of different 
parameters as obtained in present study. Hematological 
parameters Hb, WBC, RBC, PCV and MCHC showed 
significant (p<0.05) decrease in chromium supplemented 
chicks (Group A) as compared to control group (Group C). 
While, in the group co-treated with chromium and vitamin E 
(Group B), the value of these parameters increased. These 
values were found nearest to control level in comparison to 
chromium treated chicks.  
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Table 1: Protective effect of vitamin E on haematological parameters in hexavalent chromium treated laboratory chicks. 
Treatments  Hb 
(g/dl) 
WBC 
(103/mm3) 
RBC 
(106/mm3) 
PCV 
(%) 
MCHC 
(mg/dl) 
Cr(VI) 6.27±0.37* 13.73±1.44* 2.08±0.13* 15.67±0.93* 39.18±0.26* 
Cr(VI) +  Vitamin E 8.32±0.55** 19.77±0.49** 2.77±0.18** 20.79±1.38** 40.56±0.51** 
Control 9.32±0.15 21.40±0.53 3.10±0.05 23.31±0.38 40.54±0.65 
F- ratio 48.33 38.44 47.64 46.86 1.79NS 
Results are expressed as mean ± SE. 
* Significantly different (p< 0.05) when compared with control chicks. 
** Significantly different (p< 0.05) when compared with chromium treated chicks.  
Analysis of variance F (ANOVA) was significant for Hb, WBC, RBC and PCV. NS = non significant.  
Hb – Haemoglobin, WBC – White blood cell, RBC – Red blood cell. PCV – Packed cell volume, MCHC - Mean corpuscular hemoglobin 
concentration. 
 
 
Figure 1: Protective effect of Vitamin E on haematological 
parameters in Chromium treated chicks. 
DISCUSSION 
Blood is the most important tissues, in which changes in 
metabolic processes are going on, so abnormal alteration in 
blood parameters are the reliable indicators of toxic effects 
of drugs, chemicals and diseases. Haematological parameters 
are usually related to health status and are of diagnostic 
importance in clinical evaluation of the state of health. The 
haematological parameters tested in current study include 
haemoglobin concentration, red and white blood cell counts, 
packed cell volume and Mean corpuscular hemoglobin 
concentration showed significant (p<0.05) decrease in Cr 
treated chicks as compared to vitamin E and control group. 
Present study reveals that chromium induces anemia type of 
condition with decreased RBC and WBC count and 
haemoglobin concentration. Earlier reports showed that 
chromium exposure to rats resulted in reduction of RBC 
count and haematocrit value along with a decrease in 
haemoglobin concentration. The haemoglobin is the oxygen 
carrying pigment present in the red blood cells of 
vertebrates and synthesized in the immature erythrocytes in 
the bone marrow. The function of haemoglobin is the 
transport of oxygen from the lungs to the tissues and of 
carbon dioxide in the opposite direction and it is also 
responsible for stabilizing the oxygen pressure in the tissues.  
The erythrocytes are transporter of haemoglobin. They also 
contain a large quantity of carbonic anhydrase. All living 
bodies have a special system for combating the different 
infectious and toxic agents which is composed of the blood 
leukocytes and tissue cells derived from the leukocytes. 
These are the mobile units of the body’s protective system.   
The decrease in haemoglobin appears to be due to inhibition 
of its biosynthesis by decreasing the succinyl pool as well as 
glycine pool21. Another simplest explanation for this 
diminution in haemoglobin concentrations could be 
probably due to structural alteration of heame which 
disturbs haemoglobin synthesis and also to the inhibition of 
the enzyme system involved in the synthesis of 
haemoglobin22. This decrease may also be due to binding of 
Cr(VI) to beta-chain of haemoglobin in the erythrocyte23, 
explaining the depleted concentrations of heamoglobin.  
A significant decrease in the RBC count was observed 
because Cr(VI) can penetrate rapidly through the membrane 
of erythrocyte and enter the cell and accumulates in the 
erythrocytes24-26. When Cr(VI) was inhaled or administered 
intratracheally, intraperitoneally, or intravenously, much of 
the chromium in the blood (25 to 70%) was taken up by 
RBCs27-32. As the erythrocyte to plasma ratio of total 
chromium increases with increasing hexavalent chromium 
concentration, Corbett et al.33 proposed that the reductive 
capacity of erythrocytes was much greater than that of 
plasma and that the reduction rate of hexavalent chromium 
in erythrocytes was greater than the rate of uptake from 
plasma. 
Cr(VI) taken up by RBCs undergoes reduction to the 
trivalent form with the help of reduced glutathione29 and 
complexes with Hgb and other intracellular proteins that are 
sufficiently stable to retain chromium for a substantial 
fraction of the RBC lifetime34. This was confirmed by the 
result of an experiment where K2Cr2O7, a hexavalent 
chromium compound, introduced into plasma and 
reconstituted whole blood from three individuals was found 
to be readily reduced to Cr(III) in the concentration range of 
100–1,000 μg Cr(VI)/L33. Excess trivalent chromium in the 
RBC is sequestered until cell death34,35. Over time, the RBC-
associated chromium appears to be transferred to the spleen 
as a result of scavenging aging RBCs from the blood. The red 
blood cell chromium is currently considered as the best 
indicator of hexavalent chromium exposure as reported by 
Costa et al.36  
In this present study, along with decreased RBC count, there 
was also decrease in WBC count. This might be due to 
generalized injury caused to the hematopoietic stem cells by 
chromium treatment37. Similar disruption in hemopoitic 
mechanisms was observed by Adjroud38 after potassium 
dichromate exposure in both male and female rats. These 
findings are in co-occurrence with the findings of the Geetha 
et al.39 and Adjroud38. The reduction in WBC could be due to 
contact of Cr(VI) with biological compounds which lead to 
peroxidation of these compounds which were present in the 
cell or on its surface. It effect, some negative changes such as 
cells membrane damage due to peroxidation of unsaturated 
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fatty acids or inhibition of both mitochondrial trans-
membrane potential in rat lymphocytes39. 
Reduced hemoglobin concentration, PCV and MCHC values 
in chromium treated group were due to the intestinal 
haemorrhage resulting from the liberation of second 
generation merozoites which caused sloughing of intestinal 
mucosa with discharge of large amount of blood40. Decrease 
in RBC, Hb, PCV and MCHC level indicate anemia resulting 
due to iron deficiency and its decreased utilization for Hb 
synthesis, so Hb concentration also decreases. Previous 
studies also noted decrease in hematological parameters 
following Cr administration i.e. in broiler41, in rats42-43 and 
fish44. 
Hematological parameters RBC, WBC, Hb, PCV and MCHC 
concentration studied in the present investigation showed a 
significant increase in vitamin E therapeutic group. Vitamin 
E acts as an antioxidant which protects cells against toxic 
effects of chromium. Antioxidants are molecules, which 
interact with free radicals and terminate the chain reaction 
before vital molecules are damaged. They donate an electron 
to stabilize a free radical. Antioxidants have long been 
known to reduce the free radical mediated oxidative stress 
caused by elements and compounds in the environment45,46. 
Vitamin E is synthesized by plants and is an antioxidant that 
protects all membranes and other fat-soluble parts of the 
body, such as low-density lipoprotein cholesterol, from 
damage. Vitamin E is absorbed from the intestine through 
lymph. It circulates through the body plasma in associations 
with beta-lipoprotein.  
Vitamin E is a natural component of the membrane lipid 
bilayer and thus helps to maintain membrane stability47. The 
molecular and cellular effects of vitamin E have been 
explained either by acting as an antioxidant preventing 
damage to membranes or proteins and regulating their 
activity by specifically scavenging reactive oxygen 
species48,49 or by interacting and regulating specific enzymes 
and influencing cellular structure such as membrane and 
lipid domains50. Vitamin E may effectively minimize lipid 
peroxidation in biological systems51-53. Vitamin E is the 
major chain-breaking antioxidant in body tissues and is 
considered the first line of defense against lipid 
peroxidation, protecting cell membranes an early stage of 
free radical attack. 
 Present study showed decrease in haematological 
parameters after chromium treatment. Co-treatment with 
antioxidant (vitamin E) increased haematological 
parameters nearest to control level. This might be due to the 
supplemented vitamin E increase in oxygen carrying 
capacity of hemoglobin. Therefore, vitamin E is an important 
antioxidant which protects the organs from harmful effects 
of chromium. 
CONCLUSION 
From the present study it may be concluded that the 
haematological profile showed a significant decrease in the 
overall mean values of Hb, RBC, WBC, PCV, MCHC at 
significant (p<0.05) level in comparison with control chicks. 
While, the chicks supplemented with vitamin E along with 
chromium shows significant increase in all these 
hematological parameters. Hence, it can be concluded that 
the progressive toxic effect of hexavalent chromium can be 
moderately reduced by supplying vitamin E in laboratory 
chicks. 
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